BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12024760)

  • 1. Divestiture: strategy's missing link.
    Dranikoff L; Koller T; Schneider A
    Harv Bus Rev; 2002 May; 80(5):74-83, 133. PubMed ID: 12024760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating corporate advantage.
    Collis DJ; Montgomery CA
    Harv Bus Rev; 1998; 76(3):70-83. PubMed ID: 10179655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFOs and strategists: forging a common framework.
    Rappaport A
    Harv Bus Rev; 1992; 70(3):84-91. PubMed ID: 10118005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value acceleration: lessons from private-equity masters.
    Rogers P; Holland T; Haas D
    Harv Bus Rev; 2002 Jun; 80(6):94-101, 153. PubMed ID: 12048998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If private equity sized up your business.
    Pozen RC
    Harv Bus Rev; 2007 Nov; 85(11):78-87, 152. PubMed ID: 18159788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of corporate venture capital.
    Chesbrough HW
    Harv Bus Rev; 2002 Mar; 80(3):90-9, 133. PubMed ID: 11894386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored, not benchmarked. A fresh look at corporate planning.
    Campbell A
    Harv Bus Rev; 1999; 77(2):41-8, 50, 189. PubMed ID: 10387771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building deals on bedrock.
    Harding D; Rovit S
    Harv Bus Rev; 2004 Sep; 82(9):121-8, 138. PubMed ID: 15449861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative value of growth.
    Mass NJ
    Harv Bus Rev; 2005 Apr; 83(4):102-12, 134. PubMed ID: 15807043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's wrong with strategy?
    Campbell A; Alexander M
    Harv Bus Rev; 1997; 75(6):42-51. PubMed ID: 10174797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming corner-office strategy into frontline action.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 2001 May; 79(5):72-9, 164. PubMed ID: 11345913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation killers: how financial tools destroy your capacity to do new things.
    Christensen CM; Kaufman SP; Shih WC
    Harv Bus Rev; 2008 Jan; 86(1):98-105, 137. PubMed ID: 18271321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating new growth platforms.
    Laurie DL; Doz YL; Sheer CP
    Harv Bus Rev; 2006 May; 84(5):80-90, 156. PubMed ID: 16649700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopia management: multihospital portfolio planning.
    Irish GG
    Health Care Strateg Manage; 1987 Oct; 5(10):4-10. PubMed ID: 10302000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond offshoring: assess your company's global potential.
    Farrell D
    Harv Bus Rev; 2004 Dec; 82(12):82-90, 148. PubMed ID: 15605568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Match your sales force structure to your business life cycle.
    Zoltners AA; Sinha P; Lorimer SE
    Harv Bus Rev; 2006; 84(7-8):80-9, 188. PubMed ID: 16846191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A real-world way to manage real options.
    Copeland T; Tufano P
    Harv Bus Rev; 2004 Mar; 82(3):90-9, 128. PubMed ID: 15029793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charting your company's future.
    Kim WC; Mauborgne R
    Harv Bus Rev; 2002 Jun; 80(6):76-83, 153. PubMed ID: 12048996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.